Latest News in the pharma Industry
Top Stories
Humana & Pfizer Form Partnership for Health Care Improvement
14 Oct 2011
The partnership will bring researchers and health care experts to study key issues and deliver interventions to reduce inefficiencies in the management of chronic conditions.
Read more
EU Approves Teva & Cephalon Acquisition
14 Oct 2011
With this approval from the European Commission, the two companies have now obtained all regulatory approvals required to close the transaction.
Read more
Pfizer & deCODE Ink Pact for Sequence Variants Discovery
14 Oct 2011
The two companies will jointly analyze patient genomes to search for sequence variants that would be useful for understanding drug targets and discovering novel drug targets.
Read more
Canada's Paladin Labs Acquires Labopharm
13 Oct 2011
Canadian pharmaceutical firm Paladin Labs completes the acquisition of drug developer Labopharm. The acquisition will help them build upon their existing operational capabilities.
Read more
GlycoMimetics & Pfizer Ink Licensing Deal
12 Oct 2011
The potential value of the agreement for GlycoMimetics is approximately $340 million, including an upfront payment as well as development, regulatory and commercial milestones.
Read more
BMS Foundation Collaborates with WHO Stop TB Department
12 Oct 2011
The collaboration is established for a two-year pilot initiative to strengthen community based prevention, care and control of tuberculosis including co-infection with HIV in five African countries.
Read more
EMA Supports World Arthritis Day
12 Oct 2011
World Arthritis Day is held each year on 12 October. To date, 18 medicines for patients with rheumatoid arthritis have been authorised on the recommendation of the Agency.
Read more
US Signs MoU with Russia to Improve Medicine Quality
12 Oct 2011
The two countries will cooperate in several fields to improve the quality of medicines in their respective countries.
Read more
German Biotech Firm Apceth Extending Top Management
11 Oct 2011
German biotech company Apceth has extended its top management after Prof. Ralf Huss, previously Global Head of the Therapeutic Cell Initiative at Roche, joined the management board of apceth on October 1st.
Read more
AstraZeneca Plans New $200M Manufacturing Facility in China
11 Oct 2011
The new site will produce both intravenous and oral solid medicines and will enable AstraZeneca to meet the growing demand for its products in the country.
Read more
AstraZeneca to Cut 400 Jobs in the US
11 Oct 2011
The decision of the job cuts comes as AstraZeneca faces increasing pressure from generics as the company approaches a 2016 patent cliff.
Read more
Exonhit Enters Into Research Agreement With Pfizer
11 Oct 2011
French biotech company Exonhit will work with Pfizer for the identification of new Alzheimer's disease biomarkers.
Read more